115 related articles for article (PubMed ID: 11011574)
1. [Assessment of the formation of interferon neutralizing antibodies and their influence on the effectiveness of interferon therapy in children with juvenile respiratory papillomatosis].
Nurmukhametov RKh; Onufrieva EK; Soldatskiĭ IuL; Mezentseva MV; Kas'ianova NV; Tsvetnova MV; Kol'tsov VD
Vestn Otorinolaringol; 2000; (4):22-5. PubMed ID: 11011574
[TBL] [Abstract][Full Text] [Related]
2. [Antibodies against alpha-2 and gamma-interferons affect the course of juvenile respiratory papillomatosis in children treated with alpha-2 interferon preparations].
Kol'tsov VD; Onufrieva EK; Nurmukhamedov RKh; Malinovskaya VV; Yershov FI
Vestn Otorinolaringol; 1997; (4):13-5. PubMed ID: 9334008
[TBL] [Abstract][Full Text] [Related]
3. Antibodies in patients with recurrent respiratory papillomatosis treated with lymphoblastoid interferon.
Thurmond LM; Brand CM; Leventhal BG; Finter NB; Johnston JM
J Lab Clin Med; 1991 Sep; 118(3):232-40. PubMed ID: 1919296
[TBL] [Abstract][Full Text] [Related]
4. [Interferon therapy and immunotherapy in children with respiratory papillomatosis].
Tsvetkov EA; Sel'kov SA; Chmyreva NN
Vestn Otorinolaringol; 2002; (2):34-6. PubMed ID: 12056158
[TBL] [Abstract][Full Text] [Related]
5. [Assessment of the formation of antibodies to interferon in patients with juvenile respiratory papillomatosis on interferon therapy].
Kol'tsov VD; Chireshkin DG; Onufrieva EK; Nurmukhametov RKh; Malinovskaia VV; Ershov FI
Vestn Otorinolaringol; 1996; (4):25-7. PubMed ID: 8966873
[TBL] [Abstract][Full Text] [Related]
6. [Contemporary status of the issues in the treatment of children with respiratory papillomatosis].
Zenger VG; Ashurov ZM
Vestn Otorinolaringol; 2000; (4):17-21. PubMed ID: 11011573
[TBL] [Abstract][Full Text] [Related]
7. [Experience in the use of viferon suppositories in young children with juvenile respiratory papillomatosis (preliminary report)].
Onufrieva EK; Malinovskaia VV; Maslova IV; Nurmukhametov RKh; Kol'tsov VD
Vestn Otorinolaringol; 1996; (4):32-3. PubMed ID: 8966876
[TBL] [Abstract][Full Text] [Related]
8. [Antibodies to alpha-2A interferon in children with juvenile respiratory papillomatosis].
Kol'tsov VD; Onufrieva EK; Chireshkin DG; Malinovskaia VV; Ershov FI
Vestn Otorinolaringol; 1995; (5):24-6. PubMed ID: 7502448
[TBL] [Abstract][Full Text] [Related]
9. [Effects of human papilloma virus types on course of juvenile respiratory papillomatosis and effectiveness of interferon therapy in children].
Nurmukhametov RKh; Onufrieva EK; Soldatskiĭ IuL; Brodskiĭ MIu
Vestn Otorinolaringol; 2000; (2):37-40. PubMed ID: 10771610
[TBL] [Abstract][Full Text] [Related]
10. [The influence of interferon alpha neutralizing antibodies on the therapeutic effectiveness in patients with chronic viral hepatitis].
Tong F; Tang Y; Bai J
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1999 Dec; 13(4):345-7. PubMed ID: 12759973
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of immunocompetency in juvenile laryngeal papillomatosis.
Perrick D; Wray BB; Leffell MS; Harmon JD; Porubsky ES
Ann Allergy; 1990 Jul; 65(1):69-72. PubMed ID: 2368934
[TBL] [Abstract][Full Text] [Related]
12. [Viferon treatment of recurrent respiratory papillomatosis in children].
Nurmukhametov RKh; Onufrieva EK; Soldatskiĭ IuL; Maslov IV; Tikhonenkova LP; Shchepin NV; Kol'tsov VD
Vestn Otorinolaringol; 2001; (5):47-9. PubMed ID: 11699097
[No Abstract] [Full Text] [Related]
13. [The treatment of laryngeal papillomas with a combined therapy: antiviral and immunostimulating].
Sarău M; Topciu V; Marin I; Mihăilescu R
Bacteriol Virusol Parazitol Epidemiol; 1993; 38(3-4):82-6. PubMed ID: 8173218
[No Abstract] [Full Text] [Related]
14. [Pediatric laryngeal papillomatosis: our experience (three cases)].
Rodrigo Chiner O; Gisbert Aguilar J; Sánchez Alcón MD; Morera Pérez C
Acta Otorrinolaringol Esp; 1995; 46(5):365-6. PubMed ID: 8554807
[TBL] [Abstract][Full Text] [Related]
15. [Molecular-biological aspects of juvenile respiratory papillomatosis and its combined treatment].
Geraĭn V; Chireshkin DG
Vestn Otorinolaringol; 1996; (4):3-8. PubMed ID: 8966875
[TBL] [Abstract][Full Text] [Related]
16. [Efficacy of indinol in antirecurrence therapy of juvenile respiratory papillomatosis].
Soldatskiĭ IuL; Kiselev VI; Onufrieva EK; Steklov AM; Shchepin NV; Strygina IuV; Gasparian SF; Pogosova IE
Vestn Otorinolaringol; 2006; (1):46-8. PubMed ID: 16482011
[TBL] [Abstract][Full Text] [Related]
17. [Juvenile papillomatosis of the larynx].
Krajina Z; Lenarcić-Cepelja I; Jusić D; Mazuran R; Vranesić D; Stavjenić A
Lijec Vjesn; 1989 Nov; 111(11):419-23. PubMed ID: 2636300
[TBL] [Abstract][Full Text] [Related]
18. Interferon alpha-2b as adjuvant treatment of recurrent respiratory papillomatosis in Cuba: National Programme (1994-1999 report).
Nodarse-Cuní H; Iznaga-Marín N; Viera-Alvarez D; Rodríguez-Gómez H; Fernández-Fernández H; Blanco-López Y; Viada-González C; López-Saura P;
J Laryngol Otol; 2004 Sep; 118(9):681-7. PubMed ID: 15517700
[TBL] [Abstract][Full Text] [Related]
19. Studies of the effectiveness of interferon alpha treatment for chronic hepatitis C in children.
Czerwionka-Szaflarska M; Chrobot A; Szaflarska-Szczepanik A
Med Sci Monit; 2000; 6(5):964-70. PubMed ID: 11208439
[TBL] [Abstract][Full Text] [Related]
20. [Current approaches to combined treatment of recurrent respiratory papillomatosis].
Pluzhnikov MS; Riabova MA; Karpishchenko SA; Katinas EB
Vestn Otorinolaringol; 2008; (4):29-37. PubMed ID: 18837150
[No Abstract] [Full Text] [Related]
[Next] [New Search]
